To address this hypothesis, we treated cells with the mitochondrial ATPase inhibitor oligomycin, and found that 100 nM oligomycin treatment decreased ATP levels in breast cancer cells (Figures 2A,B, left panel). This evidence concerns the gene ATP5F1E and breast cancer.